Disclosed in the present invention is the use of 5α-androstane (alkyl)-3β,5,6β-triol in preparing neuroprotective drugs. The compound has significant protective effects on neuron injuries induced by cerebral ischemia, spinal cord ischemia and hypoxia, and has no obvious toxic side effects under the effective dose thereof.